Asthma Market, Pipeline, and Competition Analysis Report, 2024: Features Insights on 90+ Companies and 100+ Pipeline Drugs, Including Dexpramipexole, TQC2731, and SHR-1703
April 11, 2024 11:18 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Asthma - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...